Selected research
Industry Research
Strep Throat Treatment Industry Research Report 2026
Market perspective
The global Strep Throat Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Strep Throat Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Strep Throat Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Strep Throat Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Strep Throat Treatment include Johnson & Johnson, Novartis, Merck & co., Roche, Eli Lily, Pfizer, Bayer, Bristol-Myers Squibb and Astra Zeneca, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Strep Throat Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Strep Throat Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Strep Throat Treatment Market by Company
Johnson & Johnson
Novartis
Merck & co.
Roche
Eli Lily
Pfizer
Bayer
Bristol-Myers Squibb
Astra Zeneca
Bausch Health
Abbott Laboratories
Strep Throat Treatment Segment by Type
Penicillin
Amoxicillin
Strep Throat Treatment Segment by Application
Hospitals
Diagnostic Laboratories
Specialty Clinics
Strep Throat Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Strep Throat Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Strep Throat Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Strep Throat Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Strep Throat Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Penicillin
- Amoxicillin
Applications
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
Companies covered
- Johnson & Johnson
- Novartis
- Merck & co.
- Roche
- Eli Lily
- Pfizer
- Bayer
- Bristol-Myers Squibb
- Astra Zeneca
- Bausch Health
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Strep Throat Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Penicillin
- 2.2.3 Amoxicillin
- 2.3 Strep Throat Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Diagnostic Laboratories
- 2.3.4 Specialty Clinics
- 2.4 Assumptions and Limitations
3 Strep Throat Treatment Breakdown Data by Type
- 3.1 Global Strep Throat Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Strep Throat Treatment Forecasted Market Size by Type (2027-2032)
4 Strep Throat Treatment Breakdown Data by Application
- 4.1 Global Strep Throat Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Strep Throat Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Strep Throat Treatment Market Perspective (2021-2032)
- 5.2 Global Strep Throat Treatment Growth Trends by Region
- 5.2.1 Global Strep Throat Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Strep Throat Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Strep Throat Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Strep Throat Treatment Market Dynamics
- 5.3.1 Strep Throat Treatment Industry Trends
- 5.3.2 Strep Throat Treatment Market Drivers
- 5.3.3 Strep Throat Treatment Market Challenges
- 5.3.4 Strep Throat Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Strep Throat Treatment Players by Revenue
- 6.1.1 Global Top Strep Throat Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Strep Throat Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Strep Throat Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Strep Throat Treatment Head Office and Area Served
- 6.4 Global Strep Throat Treatment Players, Product Type & Application
- 6.5 Global Strep Throat Treatment Manufacturers Established Date
- 6.6 Global Strep Throat Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Strep Throat Treatment Market Size (2021-2032)
- 7.2 North America Strep Throat Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Strep Throat Treatment Market Size by Country (2021-2026)
- 7.4 North America Strep Throat Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Strep Throat Treatment Market Size (2021-2032)
- 8.2 Europe Strep Throat Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Strep Throat Treatment Market Size by Country (2021-2026)
- 8.4 Europe Strep Throat Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Strep Throat Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Strep Throat Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Strep Throat Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Strep Throat Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Strep Throat Treatment Market Size (2021-2032)
- 10.2 South America Strep Throat Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Strep Throat Treatment Market Size by Country (2021-2026)
- 10.4 South America Strep Throat Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Strep Throat Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Strep Throat Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Strep Throat Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Strep Throat Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Strep Throat Treatment Business (2021-2026)
- 12.1.4 Johnson & Johnson Strep Throat Treatment Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 Novartis
- 12.2.1 Novartis Company Information
- 12.2.2 Novartis Business Overview
- 12.2.3 Novartis Revenue in Strep Throat Treatment Business (2021-2026)
- 12.2.4 Novartis Strep Throat Treatment Product Portfolio
- 12.2.5 Novartis Recent Developments
- 12.3 Merck & co.
- 12.3.1 Merck & co. Company Information
- 12.3.2 Merck & co. Business Overview
- 12.3.3 Merck & co. Revenue in Strep Throat Treatment Business (2021-2026)
- 12.3.4 Merck & co. Strep Throat Treatment Product Portfolio
- 12.3.5 Merck & co. Recent Developments
- 12.4 Roche
- 12.4.1 Roche Company Information
- 12.4.2 Roche Business Overview
- 12.4.3 Roche Revenue in Strep Throat Treatment Business (2021-2026)
- 12.4.4 Roche Strep Throat Treatment Product Portfolio
- 12.4.5 Roche Recent Developments
- 12.5 Eli Lily
- 12.5.1 Eli Lily Company Information
- 12.5.2 Eli Lily Business Overview
- 12.5.3 Eli Lily Revenue in Strep Throat Treatment Business (2021-2026)
- 12.5.4 Eli Lily Strep Throat Treatment Product Portfolio
- 12.5.5 Eli Lily Recent Developments
- 12.6 Pfizer
- 12.6.1 Pfizer Company Information
- 12.6.2 Pfizer Business Overview
- 12.6.3 Pfizer Revenue in Strep Throat Treatment Business (2021-2026)
- 12.6.4 Pfizer Strep Throat Treatment Product Portfolio
- 12.6.5 Pfizer Recent Developments
- 12.7 Bayer
- 12.7.1 Bayer Company Information
- 12.7.2 Bayer Business Overview
- 12.7.3 Bayer Revenue in Strep Throat Treatment Business (2021-2026)
- 12.7.4 Bayer Strep Throat Treatment Product Portfolio
- 12.7.5 Bayer Recent Developments
- 12.8 Bristol-Myers Squibb
- 12.8.1 Bristol-Myers Squibb Company Information
- 12.8.2 Bristol-Myers Squibb Business Overview
- 12.8.3 Bristol-Myers Squibb Revenue in Strep Throat Treatment Business (2021-2026)
- 12.8.4 Bristol-Myers Squibb Strep Throat Treatment Product Portfolio
- 12.8.5 Bristol-Myers Squibb Recent Developments
- 12.9 Astra Zeneca
- 12.9.1 Astra Zeneca Company Information
- 12.9.2 Astra Zeneca Business Overview
- 12.9.3 Astra Zeneca Revenue in Strep Throat Treatment Business (2021-2026)
- 12.9.4 Astra Zeneca Strep Throat Treatment Product Portfolio
- 12.9.5 Astra Zeneca Recent Developments
- 12.10 Bausch Health
- 12.10.1 Bausch Health Company Information
- 12.10.2 Bausch Health Business Overview
- 12.10.3 Bausch Health Revenue in Strep Throat Treatment Business (2021-2026)
- 12.10.4 Bausch Health Strep Throat Treatment Product Portfolio
- 12.10.5 Bausch Health Recent Developments
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Company Information
- 12.11.2 Abbott Laboratories Business Overview
- 12.11.3 Abbott Laboratories Revenue in Strep Throat Treatment Business (2021-2026)
- 12.11.4 Abbott Laboratories Strep Throat Treatment Product Portfolio
- 12.11.5 Abbott Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst